Bodal Chemicals Ltd

Bodal Chemicals Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Bodal Chemicals Ltd

₹ 74.4 0.26%
11 Jun - close price
bodal.com BSE: 524370 NSE: BODALCHEM
About

Bodal Chemicals Limited is one of India’s leading integrated Dyestuff companies and is the largest domestic manufacturer of Dye Intermediates. It offers a wide range of Dyestuffs, Dye Intermediates, Basic Chemicals, and its variants to diverse customers across India and the world. [1]

Key Points

Product Portfolio (200+ products)[1]
Basic Chemicals (12 products)
Dye Intermediates (25 products)
Dyestuffs (175 products)
Chlor Alkali (6 products)
New Product Addition: Benzene Derivatives (5 products)

Website BSE NSE
  • Market Cap ₹ 937 Cr.
  • Current Price ₹ 74.4
  • High / Low ₹ 88.0 / 49.6
  • Stock P/E 47.6
  • Book Value ₹ 87.7
  • Dividend Yield 0.00 %
  • ROCE 5.10 %
  • ROE 1.80 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Stock is trading at 0.85 times its book value

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 4.88% over past five years.
  • Tax rate seems low
  • Company has a low return on equity of 2.14% over last 3 years.
  • Dividend payout has been low at 1.10% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Dyes And Pigments

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
597 459 401 321 390 332 330 339 394 422 429 443 451
544 409 369 296 363 310 307 315 368 388 396 399 404
Operating Profit 54 50 32 25 27 22 23 24 25 34 33 44 47
OPM % 9% 11% 8% 8% 7% 7% 7% 7% 6% 8% 8% 10% 10%
3 4 2 2 4 9 6 5 5 2 5 1 2
Interest 6 12 7 10 12 13 13 12 16 21 20 20 21
Depreciation 12 12 12 14 15 15 14 15 17 17 17 17 17
Profit before tax 38 29 14 3 5 3 2 2 -2 -1 1 8 12
Tax % 24% 23% 28% 11% 39% 31% 26% 49% -200% -19% 124% 34% -25%
29 23 10 2 3 2 1 1 2 -1 -0 5 14
EPS in Rs 2.52 1.95 0.84 0.19 0.22 0.18 0.10 0.08 0.16 -0.09 -0.02 0.43 1.15
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
960 1,043 908 1,233 1,142 1,424 1,375 1,226 2,055 1,574 1,395 1,745
770 859 758 1,007 946 1,187 1,237 1,140 1,835 1,441 1,284 1,586
Operating Profit 189 184 150 226 196 236 138 87 220 133 111 159
OPM % 20% 18% 16% 18% 17% 17% 10% 7% 11% 8% 8% 9%
-70 5 19 15 8 13 10 16 -2 12 9 11
Interest 47 27 12 9 5 9 19 17 29 41 54 82
Depreciation 25 22 26 29 12 21 28 30 47 53 60 69
Profit before tax 47 139 131 204 186 219 101 55 142 51 5 19
Tax % 35% 34% 34% 35% 33% 35% 15% 28% 31% 25% -37% 4%
30 92 86 133 122 141 86 40 99 38 6 18
EPS in Rs 2.76 8.41 7.88 12.18 10.03 11.72 7.12 3.43 8.51 3.03 0.51 1.47
Dividend Payout % 0% 0% 8% 7% 8% 7% 11% 23% 9% 3% 0% 0%
Compounded Sales Growth
10 Years: 5%
5 Years: 5%
3 Years: -5%
TTM: 25%
Compounded Profit Growth
10 Years: -14%
5 Years: -26%
3 Years: -44%
TTM: 61%
Stock Price CAGR
10 Years: 11%
5 Years: 6%
3 Years: -8%
1 Year: -1%
Return on Equity
10 Years: 10%
5 Years: 4%
3 Years: 2%
Last Year: 2%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 22 22 22 22 24 24 24 24 24 25 25 25
Reserves 43 135 213 341 673 805 907 957 1,028 1,053 1,057 1,080
397 234 143 151 181 171 257 454 676 760 904 911
131 144 132 193 194 290 267 314 385 283 294 337
Total Liabilities 593 534 510 707 1,072 1,290 1,455 1,749 2,113 2,120 2,281 2,353
168 190 192 222 437 609 656 804 817 967 1,314 1,301
CWIP 9 3 0 9 19 26 7 14 70 193 68 61
Investments 1 2 2 17 17 6 3 6 0 0 13 0
415 339 316 459 599 650 789 924 1,227 960 886 991
Total Assets 593 534 510 707 1,072 1,290 1,455 1,749 2,113 2,120 2,281 2,353

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
49 198 131 104 7 186 10 -13 -14 290 204 114
-17 -35 -23 -67 -256 -128 -79 -168 -170 -315 -263 -37
-32 -162 -109 -23 236 -51 76 178 181 33 66 -73
Net Cash Flow 1 0 -1 14 -13 7 7 -3 -3 8 7 3

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 86 69 67 56 91 85 121 139 105 97 100 83
Inventory Days 72 43 57 60 59 86 91 141 141 119 139 139
Days Payable 66 62 67 73 79 91 87 102 81 72 102 97
Cash Conversion Cycle 92 50 58 43 71 79 124 178 165 144 137 125
Working Capital Days 89 66 75 63 115 90 133 176 137 141 138 125
ROCE % 39% 39% 35% 46% 27% 24% 11% 5% 12% 5% 3% 5%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
58.94% 58.87% 57.47% 57.47% 57.39% 57.39% 57.39% 57.39% 57.39% 57.32% 57.32% 57.32%
3.06% 3.09% 2.42% 2.43% 2.37% 0.45% 0.30% 0.77% 0.19% 0.67% 0.32% 0.32%
0.17% 0.16% 0.16% 0.14% 0.01% 0.03% 0.01% 0.01% 0.01% 0.01% 0.00% 0.00%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
37.82% 37.88% 39.94% 39.97% 40.22% 42.12% 42.29% 41.82% 42.41% 42.00% 42.36% 42.35%
No. of Shareholders 59,67963,24764,22564,79566,07377,81676,86777,33277,49581,42078,83178,163

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls